Finance

Lists
Why is BNTC up 4.48%?
Dive Deeper
BNTC:NASDAQ
Benitec Biopharma Inc
$10.02
+4.48%
(+0.43) 1D
Sep 28, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BNTC...
Open
$9.57
High
$10.04
Low
$9.31
Mkt. cap
349.52M
Avg. vol.
160.34K
Volume
0.00
52-wk high
$16.76
52-wk low
$9.26
EPS
-$0.98
Beta
0.27
Shares outstanding
34.88M
No. of employees
24
Open
$9.57
High
$10.04
Low
$9.31
Mkt. cap
349.52M
Avg. vol.
160.34K
Volume
0.00
52-wk high
$16.76
52-wk low
$9.26
EPS
-$0.98
Beta
0.27
Shares outstanding
34.88M
No. of employees
24
News stories
From web sources and news partners
About Benitec Biopharma Inc
CEO-
Employees24
Founded-
Headquarters-
SectorBiotechnology
Analyst ratings
Based on 4 analysts giving stock ratings to BNTC in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for BNTC in the last 3 months.
Highest
Current $10.02
$32.00 (+219.36%)
Average
$24.67 (+146.21%)
Lowest
$17.00 (+69.66%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$32.00
+219.4%
09/28/2026
Ritu Baral
TD Cowen
Buy
Maintained
-
-
09/15/2026
Cory Kasimov
Evercore ISI
Buy
Maintained
$25.00
+149.5%
09/15/2026
Yun Zhong
Wedbush
Buy
Reiterated
$17.00
+69.7%
09/15/2026
Debjit Chattopadhyay
Guggenheim
Hold
Downgraded
-
-
06/10/2026
Unknown Analyst
Leerink Partners
Buy
Reiterated
$18.00
+79.6%
05/15/2026
Silvan Tuerkcan
Citizens JMP
Buy
Maintained
$22.00
+119.6%
11/04/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.70M
3.37M
5.83M
6.30M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13.48M
6.43M
7.54M
7.28M
Operating expense
17.18M
9.80M
13.38M
13.58M
Total operating expenses
17.18M
9.80M
13.38M
13.58M
Operating income
-17.18M
-9.80M
-13.38M
-13.58M
Other non operating income
-126.00K
-84.00K
19.00K
-17.00K
EBT including unusual items
-16.15M
-8.96M
-11.84M
-11.94M
EBT excluding unusual items
-16.15M
-8.96M
-11.84M
-11.94M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-16.15M
-8.96M
-11.84M
-11.94M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
1.04M
1.01M
1.39M
1.59M
Interest expense
-
-
-
-
Net interest expenses
1.04M
1.01M
1.39M
1.59M
Depreciation and amortization charges
-
-
-
-
EBITDA
-17.16M
-9.79M
-13.36M
-13.57M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google apps